Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Bulletin from the Extraordinary General Meeting of Lipidor AB (publ)

STOCKHOLM, Sweden, 8 June 2021: The following resolutions were passed at the extraordinary general meeting (the “EGM”) of Lipidor (publ) (the “Company”) on 8 June 2021. Due to the covid-19 pandemic, the Company’s extraordinary general meeting was carried out through advance voting (postal voting) only.Incentive programme in the subsidiary Emollivet AB The EGM resolved, in accordance with the Board of Directors’ proposal, to approve of the subsidiary Emollivet AB’s resolution to adopt an incentive programme to the management in Emollivet AB consisting of warrants. In short, the incentive

Bulletin from the annual general meeting of Lipidor AB (publ)

STOCKHOLM, Sweden, 8 June 2021: The following resolutions were passed at the annual general meeting (the “AGM”) of Lipidor (publ) (the “Company”) on 8 June 2021. Due to the covid-19 pandemic, the Company’s annual general meeting was carried out through advance voting (postal voting) only.Adoption of income statement and balance sheet and discharge from liability The AGM resolved to adopt the income statement for the financial year 2020 as well as the balance sheet and consolidated balance sheet as of 31 December 2020. The members of the board of directors and the managing director were

EG7’s CEO and Chairman Sell Shares – Remain Committed Long-Term Shareholders

Enad Global 7’s CEO and Chairman, Robin Flodin and Alexander Albedj have together sold 1,313,836 shares between 4-8 June 2021 which corresponds to 24% of their holdings, respectively. They have decided to each keep 76% of their holdings and have signed a lock-up agreement stating that no additional shares can be sold for a period of 360 days. They still hold 4,182,961 shares, corresponding to an investment of approximately SEK 378 million based on the closing price as of 7 June 2021. Comment by Robin Flodin, CEO of EG7:“Due to private financial reasons, the chairman and I have decided

The nomination committee’s proposals for the myFC Board of Directors

The nomination committee of myFC will not name a replacement for Alex Guy on the Board of Directors ahead of the upcoming Annual General Meeting on June 10.As previously announced, the Nomination Committee proposes re-election of the Board members Ulf Henning, Johnny Bräster and Klaus Wiemers. A replacement for Alex Guy, who has declined re-election, has not yet been named. Therefore, item 10d in the postal voting form will be omitted. The intention to add a fourth member to the Board of Director remains, but this will be done at a later time.   As previously announced, the Annual

The Stryze Group acquires seven further Amazon shops

Nine-digit annual turnover in sight / Acquisitions expand The Stryze Group's portfolio with highly rated, consumer-preferred products that offer strong growth potentialBerlin, June 8, 2021 – The Stryze Group acquired seven Amazon shops in the month of May. These acquisitions alone will contribute between 20 and 25 million euros in sales over the next twelve months. With the acquired brands, Stryze delivers sought-after consumer goods to millions of satisfied customers – worldwide. This is because Stryze not only buys German brands, but also successful brands from abroad. The most recent

Raytelligence receives MDR labeling from the Medical Products Agency

EaZense has been registered with the Medical Products Agency and certified under MDR. This means that the product is approved in accordance with the EU regulation on medical devices that ensures the safety and performance of medical devices. EaZense has been CE marked according to previously applicable directives for medical devices, MDD. The EU's new Medical Devices Regulation (MDR) replaced the MDD in May 2021. Like all medical technology companies with products on the European market, Raytelligence has had to adapt its operations to meet the new requirements for CE marking of the

Hexagon introduces HxGN Connect, a SaaS workspace enabling seamless, citywide collaboration, planning and response

Hexagon AB, a global leader in sensor, software and autonomous solutions, today announced the introduction of HxGN Connect, a SaaS workspace for citywide collaboration enabling government agencies and other diverse organisations to share data and coordinate action for ad-hoc, routine and emergency situations.Hosted in Microsoft Azure, HxGN Connect provides a networked workspace and unified view of information within and between different entities. Participants can actively collaborate and securely share data as events unfold, overcoming the technical and political barriers that often

Knowit publishes prospectus

On 5 May 2021, Knowit Aktiebolag (publ) announced the acquisition of Cybercom Intressenter AB (“Cybercom“). The total consideration amounts to approximately SEK 2.2 billion[1] of which approximately SEK 442 million is paid in cash and through a non-cash issue of 5,760,883 newly issued shares to the sellers of Cybercom. At the Extraordinary General Meeting on 28 May 2021, the Board of Directors was authorized to carry out the non-cash issue.The prospectus that has been prepared in connection with the admission to trading on Nasdaq Stockholm of the 5,760,883 shares in the forthcoming non-cash

UPM has completed employee consultation process in Finland

(UPM, Helsinki, 8 June 2021 at 12:30 EEST) – UPM has completed the employee consultation process in Finland started in April. The company will improve efficiency in global functions by reorganising and streamlining the operations. As a result, the number of employments in Finland will decrease by 28. In Germany and Austria, the process is still on-going. UPM provides support for employees who are affected by the reductions. It includes outplacement services and training opportunities that support re-employment of the affected employees. In 2020, the company decreased fixed and

Article about Gene and Cell Therapy

Professor Edvard Smith, CMO NextCell Pharma AB ("NextCell" or the "Company") has written a review article in the Swedish Medical Journal (Läkartidningen) entitled "Gene therapy now comes in many medical specialties", together with Associate Professor Pontus Blomberg, Director of Operations; both at the Department of Laboratory Medicine, Karolinska Institutet; Karolinska Centre for Cell Therapy, Karolinska University Hospital, Stockholm.The main message of the article is that the development of gene therapy has been rapid, and more and more preparations are reaching patients and in many

Konftel Packs A Powerful Conferencing Punch As New Innovations Unveiled

Two new video conferencing solutions have been launched by industry powerhouse Konftel – featuring a dynamic and Red Dot award-winning audio innovation.The new Konftel 70 is a versatile high performance speakerphone that blends exceptional audio quality with a stylish accolade-winning design. It’s an ideal video meeting companion or can be used as a standalone or even portable solution, for huddle rooms and small/medium locations. It forms the audio centrepiece of two new video kits – the C2070 and C5070 – which are part of Konftel’s entire Climate Neutral certified portfolio. The

New Software Suite Drives Cash Cycle Innovation

ZEN Suite enables retailers, banks and CIT to connect all their cash handling devices via a single platform. Gunnebo Cash Management has launched a new modular software suite which connects with any cash handling device, cash service provider or third-party system. ZEN Suite is made up of a series of modules flexible enough for customers to build the solution they need. Features include: · Business reporting and analytics with real-time monitoring of cash levels · Remote monitoring for predictive maintenance, remote user management and upgrades · Hyperconnectivity and data

AVTECHs ClearPath service draws media attention

AVTECH recently gained attention in both Swedish and foreign media in connection with "Met Office Industry Week" together with project partners Met Office and Norwegian Airlines. Focusing on the use of high-resolution weather forecasts, AVTECH's latest product ClearPath was presented and how it already today helps airlines fly more efficient resulting in a directly reduced environmental impact. With Norwegian as the launch customer, AVTECH presented how ClearPath benefits from new high-resolution weather forecasts from the Met Office and how ClearPath enables a fuel saving of 1.6% at

Atria to include the carbon footprint of its poultry products in the packaging

Atria has expanded the calculation of the carbon footprint of its poultry products, and a label with the product’s carbon footprint will now be added to all poultry packaging. The label shows the climate impact of the product’s entire production chain in carbon dioxide equivalents. The carbon footprint has been calculated and noted per product item (kg Co2e\2\e / product). Poultry products with the carbon footprint label will be in shops around Finland in June. To avoid wasting packaging material, the carbon footprint labels will be added to products in a phased manner as the packaging

Clavister Sizes Up IAM Deployment at Major Nordics Public Agency

8 June 2021 – Örnsköldsvik, Sweden – Clavister, a leader in high-performance cybersecurity solutions, announces that a major public administration agency in the Nordics is upsizing its deployment of the Clavister Identity and Access Management solution, following an order with a value for Clavister around 2 MSEK.“We are delighted to see our deployment footprint continuing to grow within the Nordics public administration sector,” said John Vestberg, CEO at Clavister. “Clavister solutions being used by public agencies in the Nordics, a market being at the forefront of using digital identities

Indutrade strengthens Group Management for continued sustainable profitable growth

As a part of Indutrade’s strategy for continued sustainable profitable growth, and to intensify the development of the MedTech/Pharma businesses, Morgan O´Brien has been appointed SVP Business Development & President UltraPure International (UPI). The newly established position will be a part of Indutrade’s Group Management.Morgan O´Brien, currently SVP of the Business Area Flow Technology, has during the last years played a key role in the development and growth of Indutrade’s MedTech segment, particularly within the single-use niche. Under the independent brand UltraPure International (

LightAir’s new strategy yield results

Enskilda Gymnasiet signs an expanded subscription for clean and virus-free air LightAir's strategic focus on sales of air purification to offices and schools in Sweden is continuing to yield results. The LightAir Health[+] offer provides clean, virus-free air and is offered in Sweden primarily as a subscription service. The number of subscriptions is growing continuously, rising from about sixty last summer and soon exceeding three hundred.The positive market reception in Sweden is exemplified by how Enskilda Gymnasiet – an independent secondary school in operation for over 100 years –

The Riksbank’s Business Survey: “Demand is not the problem – the troubles are on the supply side”

The economic situation for major Swedish companies is becoming increasingly strong, especially for the manufacturing sector. Companies feel that the risks of the pandemic are decreasing, they are optimistic about the future, and dare to make decisions and invest. However, problems with shortages of certain important components are leading to delays and increased costs. Even so, profitability is generally good and several sectors see opportunities to raise their prices.“… the risks of the pandemic are still diminishing, the world is up and running” Manufacturing activity has continued to

IRRAS Receives Quality System Certification under MDSAP and Updated European Union Medical Device Regulation 2017 / 745

· IRRAS’ Quality Management System has been confirmed to comply with stringent standards required under both MDSAP and EU MDR programs, which also extends the company’s existing ISO 13485:2016 certification · After completion of MDSAP audit, IRRAS can now pursue product regulatory clearance in its next wave of key markets, including Australia and Brazil · Successfully completing the MDR quality audit is needed first step to qualify IRRAS’ products for CE Mark under new MDR requirementsStockholm, June 8, 2021 – IRRAS AB, a commercial-stage medical technology company with a

Herantis Pharma R&D Investor Day Highlights

Herantis Pharma Plc, Company release, 8 June 2021 at 11:00 EEST “We are delighted to host this R&D Day event, and very much look forward to providing an update on the new Herantis as a pure play CNS company and our programs fully focused on disease modifying therapeutics to address the unmet need in Parkinson’s Disease and other neurological illnesses”, commented Dr. Craig Cook, CEO of Herantis. “We are at a key juncture for the company, with solid fundamentals, fascinating science, exciting and meaningful data as we enter the next chapter for the company and our xCDNF and CDNF assets.

Swedbank invests in new platform for savings

Swedbank has decided to make one of the largest investments in digital infrastructure in the bank’s history. The investment in the savings platform is part of a long-term focus by Swedbank and the savings banks on the financial health of all private customers and SMEs in Sweden. The platform will provide the necessary infrastructure to support continuous, personalized advice and create the opportunity for new services for savings and investments.The new savings platform gives Swedbank and the savings banks the technological capability and flexibility needed to meet their customers’ needs.

Cantargia receives regulatory approval to start clinical trial investigating nadunolimab and FOLFIRINOX in pancreatic cancer

Cantargia AB today announce that the clinical trial application to investigate the antibody nadunolimab (CAN04) in combination with the FOLFIRINOX chemotherapy regimen for first line treatment of metastatic pancreatic cancer (PDAC), has been approved by the regulatory authority and the central ethics committee in France. The current estimate is to enroll the first patient in June 2021.The approvals by the Agence nationale de sécurité du médicament et des produits de santé, ANSM, and the central ethics committee, follow the previously communicated application of this CAN04 study on Mar 10,

Dicot signs development agreements with leading suppliers in formulation

Press release: Uppsala, June 8, 2021. Dicot is preparing for the initial human clinical trials. The way in which the company´s drug candidate is administered to the subjects, so-called formulation, is of the greatest importance for the studies. Therefore, agreements have been signed with two leading companies in formulation development.In parallel with animal studies, several activities are underway within Dicot's work to develop a potency drug with better properties than those of existing drugs. The next major milestone is human clinical trials planned to be launched during 2022. Prior

Power production in May 15.0 GWh

Weaker wind conditions than normal in May resulted in a power production of 15.0 GWh, compared to the month’s budget of 23.6 GWh. Halmstad, 8 June 2021 ARISE AB (publ) For further information, please contact: Daniel Johansson, CEO Arise AB, +46 702 244 133 This information is information that Arise AB is obliged to make public pursuant to the EU MarketAbuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 09.45 CET on 8 June, 2021. Regarding information about how we process your personal data we refer to

There are no items matching the current filter
There are no more items matching the current filter
Back to top